COPD Pathophysiology

Definition

Fig. 11.4 - Overlap between emphysema, chronic bronchitis, and asthma (Robbins & Kumar Basic Pathology)

Risk Factors

• Cigarette smoking - the dominant cause; ~80% of COPD is attributable to it; 35-50% of heavy smokers develop COPD
• Poor lung development early in life
• Environmental/occupational pollutant exposure
• Airway hyperresponsiveness
• Genetic factors - particularly alpha-1 antitrypsin (A1AT) deficiency (Pi locus, chromosome 14)
• Women appear more susceptible than men

Core Pathogenic Mechanisms

Fig. 11.6 - Pathogenesis of emphysema (Robbins & Kumar Basic Pathology)

1. Inflammatory Cell Recruitment and Mediators

• Key inflammatory cells: Neutrophils, alveolar macrophages, CD4+ and CD8+ T lymphocytes
• Key mediators: Leukotriene B4 (LTB4), IL-8 (chemokine), TNF-alpha, IL-13
• These mediators act as chemotactic factors (recruit more cells), proinflammatory cytokines (amplify the reaction), and growth factors (induce structural remodeling)
• Notably, eosinophils are NOT prominent in COPD (this distinguishes it from asthma)
• This inflammatory process persists even after smoking cessation
• Robbins & Kumar Basic Pathology, p. 448

2. Protease-Antiprotease Imbalance

• Inflammatory cells (especially neutrophils and macrophages) release proteases - notably neutrophil elastase and matrix metalloproteinases (MMPs)
• These enzymes degrade elastin and collagen in the alveolar walls and extracellular matrix
• Normally, antiproteases - chiefly alpha-1 antitrypsin (A1AT) - inhibit these proteases
• In smokers, oxidative stress directly inactivates A1AT, tipping the balance toward destruction
• In A1AT deficiency (homozygous Z allele, ~0.01% of US population): >80% develop symptomatic panacinar emphysema, earlier onset and more severe with smoking
• Loss of elastic tissue removes radial traction on small airways, causing airway collapse during expiration - this creates functional (dynamic) airflow obstruction without a fixed mechanical blockade

3. Oxidative Stress

• Cigarette smoke directly contains reactive oxygen species (ROS): superoxide (O2-), hydroxyl radical (OH), and hydrogen peroxide (H2O2)
• Activated macrophages and neutrophils generate additional ROS chronically
• NOX4 (NADPH oxidase 4) expression is increased in airway smooth muscle and fibroblasts in COPD
• ROS cause direct tissue injury and inflammation
• A critical consequence: ROS activate NF-kB, a transcription factor that upregulates proinflammatory cytokines (IL-8, TNF), creating a self-amplifying loop
• Cigarette smoke also inhibits histone deacetylase, further promoting proinflammatory gene expression
• Oxidative stress also inactivates A1AT, compounding the protease-antiprotease imbalance
• Fishman's Pulmonary Diseases and Disorders, p. 395

Emphysema - Anatomic Patterns

Centriacinar (Centrilobular) Emphysema

• Involves central/proximal acinus (respiratory bronchioles) with relative sparing of distal alveoli
• Both emphysematous and normal air spaces coexist within the same acinus
• More common and severe in upper lobes, apical segments
• Strongly associated with cigarette smoking - the predominant form
• About 20x more common than panacinar emphysema

Panacinar (Panlobular) Emphysema

• Uniform enlargement of the entire acinus, from respiratory bronchiole to terminal alveoli
• More common in lower lung zones
• Classically associated with alpha-1 antitrypsin deficiency

Distal Acinar (Paraseptal) Emphysema

• Affects the distal part of the acinus, near pleura and lobular septa
• Upper half of lungs more affected; can form bullae
• Classic association: spontaneous pneumothorax in young adults

Irregular Emphysema

• Irregular acinar involvement, almost always associated with scarring
• Usually clinically insignificant

Chronic Bronchitis - Pathogenesis

1. Hypertrophy of mucous glands in trachea and large bronchi (assessed by the Reid Index - ratio of submucosal gland thickness to bronchial wall thickness; normally <0.4; elevated in chronic bronchitis)
2. Goblet cell metaplasia - increase in goblet cells in smaller bronchi and bronchioles
3. Inflammation - macrophages, neutrophils, lymphocytes (NOT eosinophils)
4. Cytokine mediation - IL-13 from T cells drives mucin expression; neutrophil elastase (induced by tobacco smoke) further contributes

• Mucous plugging of bronchiolar lumen
• Luminal inflammation
• Submucosal fibrosis causing luminal narrowing
• In severe cases: bronchiolitis obliterans
• Robbins & Kumar Basic Pathology, p. 449

Airflow Obstruction Mechanics

Dynamic Hyperinflation

• Decreased elastic recoil + airflow limitation means insufficient time for passive exhalation to FRC
• Tidal breathing shifts to the upper portion of the flow-volume curve
• Results in progressive air trapping and increased TLC, FRC, and RV
• The diaphragm flattens, losing its domed shape - reducing its mechanical advantage
• In severe COPD, diaphragmatic contraction can paradoxically deflate the rib cage, making inspiration increasingly dependent on accessory muscles

Gas Exchange Abnormalities

Ventilation-Perfusion (V/Q) Mismatch

• Low V/Q areas (poorly ventilated but perfused): seen in airways disease/chronic bronchitis - cause hypoxemia
• High V/Q areas (alveolar dead space - ventilated but not perfused): seen in emphysema - waste ventilation
• Net result: inefficient gas exchange requiring higher minute ventilation to maintain normocapnia

Hypoxemia

• Results from low V/Q mismatch (the dominant mechanism in COPD, unlike diffusion limitation)
• Leads to hypoxic vasoconstriction, pulmonary hypertension, and eventually cor pulmonale

Hypercapnia (Type II Respiratory Failure)

• PaCO2 typically does not rise until FEV1 falls to ~20-25% of predicted
• Caused by:
  • Increased physiologic dead space (V/Q mismatch) - requires increased ventilation to maintain eucapnia
  • Mechanical disadvantage of the respiratory system (dynamic hyperinflation)
  • Inspiratory muscle weakness (reduced force generation per cross-sectional area, reduced myosin heavy chain content, decreased Ca2+ sensitivity)
  • Blunted ventilatory drive in some patients
• Fishman's Pulmonary Diseases and Disorders, p. 2532

"Pink Puffer" vs. "Blue Bloater" Phenotypes

Downstream Systemic Consequences

• Pulmonary hypertension / Cor pulmonale: chronic hypoxia triggers hypoxic pulmonary vasoconstriction; vascular remodeling occurs even in mild COPD
• Polycythemia: secondary to chronic hypoxemia (EPO stimulation)
• Skeletal muscle dysfunction: reduced muscle fiber force generation, myosin heavy chain content, Ca2+ sensitivity - contributes to exercise limitation
• Nocturnal desaturation: physiologic changes of sleep are poorly tolerated; REM sleep causes most severe hypoventilation (especially with diaphragmatic dysfunction)
• Exacerbations: bacterial/viral infections trigger acute inflammatory flares; do not initiate, but perpetuate and worsen the disease

Summary Flow

Smoking / noxious particles + genetic predisposition
          ↓
Airway inflammation (neutrophils, macrophages, CD4+/CD8+ T cells)
          ↓
  ┌───────────────────┬───────────────────┐
  ↓                   ↓                   ↓
Oxidative stress   Protease-antiprotease   Mucus hypersecretion
(ROS, NF-kB)       imbalance               (goblet cell metaplasia,
                  (elastase > A1AT)         mucous gland hypertrophy)
  ↓                   ↓                   ↓
Alveolar wall     Alveolar wall         Small airway disease
apoptosis/        destruction           (bronchiolitis, fibrosis)
senescence        (EMPHYSEMA)           (CHRONIC BRONCHITIS)
  └───────────────────┴───────────────────┘
                        ↓
              Airflow obstruction (irreversible)
                        ↓
          V/Q mismatch → hypoxemia → PH/cor pulmonale
          Dead space → ↑ WOB → dynamic hyperinflation
          Hypercapnia (late, when FEV1 <25%)

• Robbins & Kumar Basic Pathology - pp. 447-450
• Fishman's Pulmonary Diseases and Disorders, pp. 395, 2532
• Murray & Nadel's Textbook of Respiratory Medicine

COPD - Symptoms & Clinical Features

Key Point

Cardinal Symptoms (The Triad)

1. Dyspnea

• The dominant and most disabling symptom
• Initially exertional - worse with hills, stairs, hurrying
• Progresses insidiously over years to dyspnea at rest in severe disease
• Patients often unconsciously reduce activity to avoid breathlessness, so they under-report it
• Graded using the mMRC (Modified Medical Research Council) Dyspnea Scale:

2. Chronic Cough

• Often the first symptom to appear
• Initially intermittent - the "smoker's cough" - easily dismissed
• Becomes persistent and daily as disease advances
• May be dry or productive
• Patients may not report it spontaneously as they consider it "normal" for a smoker

3. Sputum Production

• Typically mucoid (clear/white), produced in the morning ("morning sputum")
• Reflects mucous gland hypertrophy and goblet cell metaplasia of chronic bronchitis
• Heavy, daily sputum for ≥3 months per year for ≥2 consecutive years = chronic bronchitis by definition
• Becomes purulent (yellow/green) during exacerbations (bacterial colonization/infection)

4. Wheezing

• Due to airflow turbulence through narrowed airways
• May be present at rest or only on exertion
• Particularly prominent during exacerbations
• Not specific - can also occur in asthma, heart failure

Additional Symptoms (Advanced/Severe Disease)

Comorbidities that are more common than expected in COPD: osteoporosis, depression, anxiety, cardiovascular disease, lung cancer, malnutrition, and diabetes - Washington Manual of Medical Therapeutics, p. 311

Physical Examination Signs

Inspection

• Pursed-lip breathing - creates intrinsic PEEP to prevent airway collapse during expiration; characteristic of emphysema-predominant COPD
• Barrel chest - increased AP diameter due to chronic hyperinflation (increased TLC)
• Use of accessory muscles - sternocleidomastoid, scalenes recruited due to diaphragmatic disadvantage
• Hoover's sign - paradoxical inward movement of the lateral rib cage during inspiration (flattened diaphragm)
• Central and peripheral cyanosis - in hypoxemic patients (blue bloater phenotype)
• Cachexia / weight loss - in advanced emphysema-predominant disease
• Pursed-lip breathing posture ("tripod") - leaning forward with hands on knees

Percussion

• Hyperresonance - increased air in lungs (emphysema)
• Reduced diaphragmatic excursion - diaphragm flattened and fixed by hyperinflation

Auscultation

• Reduced breath sounds - loss of lung parenchyma, air trapping
• Prolonged expiratory phase - >6 seconds on forced exhalation (hallmark of obstruction)
• Expiratory wheeze and rhonchi - may or may not be present
• Muffled heart sounds - interposed hyperinflated lung attenuates cardiac sounds

Signs of Advanced Complications

• Raised JVP, peripheral edema, loud P2 - pulmonary hypertension / cor pulmonale
• Right ventricular heave - RV hypertrophy

Important: Clubbing is NOT a feature of COPD alone - its presence should prompt evaluation for other conditions, especially lung cancer. - Washington Manual of Medical Therapeutics, p. 312

Symptom Spectrum by Disease Severity

Acute Exacerbation Symptoms

1. Increased dyspnea (beyond baseline)
2. Increased sputum volume
3. Increased sputum purulence (yellow/green)

Trigger: most commonly respiratory infections (bacterial or viral). Other triggers: air pollution, pulmonary embolism, pneumothorax, cardiac failure. - Rosen's Emergency Medicine, p. 2531

Symptom Assessment Tools

• CAT (COPD Assessment Test) - 8-item questionnaire scoring cough, sputum, chest tightness, breathlessness on stairs, home activity limitation, confidence leaving home, sleep quality, and energy (score 0-40; higher = worse)
• mMRC Dyspnea Scale - grades breathlessness 0-4
• BODE Index - multidimensional mortality predictor combining BMI, airflow Obstruction (FEV1), Dyspnea (mMRC), and Exercise capacity (6-minute walk test)

• Washington Manual of Medical Therapeutics, pp. 310-312
• Symptom to Diagnosis: An Evidence-Based Guide, 4th ed., p. 613
• Rosen's Emergency Medicine, p. 2531

COPD - Pathogenesis

Step 1: Initiation - Noxious Stimulus Exposure

Cigarette Smoke (Primary Trigger)

• Contains preformed ROS: superoxide (O₂⁻), hydroxyl radical (·OH), hydrogen peroxide (H₂O₂)
• Contains >4,000 toxic compounds including acrolein, aldehydes, and quinones
• Directly damages airway epithelial cells and mucociliary apparatus
• Disrupts tight junctions between epithelial cells

• Inhibits histone deacetylase (HDAC) - normally represses proinflammatory genes
• HDAC inhibition → unopposed histone acetylation → sustained transcription of IL-8, TNF-α, and other cytokines
• This epigenetic change is partially irreversible, explaining why inflammation persists after smoking cessation

Step 2: Innate Immune Activation

Epithelial Cell Response

• Activated by cigarette smoke via pattern recognition receptors (TLRs)
• Release IL-8 (CXCL8) - the dominant neutrophil chemoattractant in COPD
• Release LTB4 (leukotriene B4) - another potent neutrophil and macrophage chemoattractant
• Upregulate ICAM-1 and other adhesion molecules on endothelium

Macrophage Activation

• Activated by cigarette smoke components and damage-associated molecular patterns (DAMPs)
• Release: MMP-9, MMP-12 (macrophage metalloelastase), LTB4, IL-8, TNF-α
• MMP-12 is particularly critical - mice deficient in MMP-12 are protected from smoke-induced emphysema
• Also generate large quantities of ROS (via NOX2 and NOX4 enzymes)

Neutrophil Recruitment and Action

• Recruited to lung by IL-8, LTB4, and complement fragments
• Primary source of neutrophil elastase (NE) - the key destructive protease
• Also release: MMP-8, MMP-9, cathepsin G, proteinase 3
• NE degrades elastin, collagen, fibronectin, and laminin in alveolar walls
• NE also directly stimulates goblet cell mucus secretion and impairs mucociliary clearance

Step 3: Adaptive Immune Perpetuation

CD8+ T Lymphocytes (Cytotoxic T Cells)

• The hallmark lymphocyte of COPD (unlike asthma, which is CD4+/Th2 dominant)
• CD8+ T cells accumulate in airspaces and airway walls
• Release perforin and granzyme - directly induce alveolar cell apoptosis
• Also produce IFN-γ, which activates macrophages and amplifies the inflammatory loop
• Their antigen specificity is unknown - possibly reacting to smoke-modified self-antigens or cross-reacting with respiratory pathogens

CD4+ Th1 and Th17 Cells

• Th1 cells produce IFN-γ, activating macrophages
• Th17 cells produce IL-17, which further recruits neutrophils and contributes to mucus hypersecretion
• Regulatory T cell (Treg) dysfunction may prevent resolution of inflammation

Step 4: The Three Core Destructive Mechanisms

A. Protease-Antiprotease Imbalance

NORMAL:                Neutrophil elastase  ←  INHIBITED by  →  α1-Antitrypsin (A1AT)

IN COPD:               ↑↑ Neutrophil elastase  +  ↓ A1AT activity  =  NET PROTEOLYSIS

• Massive neutrophil and macrophage recruitment → ↑↑ NE, MMP-9, MMP-12
• Oxidative stress directly inactivates A1AT (oxidizes its active-site methionine)
• ROS also activate latent MMPs

• A1AT is a glycoprotein synthesized by hepatocytes; encoded at the Pi locus on chromosome 14
• It is the major inhibitor of neutrophil elastase in the lung
• ~0.01% of the population is homozygous for the Z allele (Pi*ZZ genotype)
  • Pi*ZZ → markedly reduced serum A1AT levels
  • Results in panacinar emphysema (lower lobe predominant), onset in 3rd-4th decade

  • 80% develop symptomatic emphysema; smoking dramatically accelerates this

• Even in non-deficient smokers, ROS inactivate sufficient A1AT to tip the balance toward destruction

• Degradation of elastin, collagen, and proteoglycans in alveolar walls
• Loss of alveolar wall integrity → irreversible airspace enlargement (emphysema)
• Loss of the elastic fiber scaffold around small airways → reduced radial traction → dynamic airway collapse during expiration

Panacinar emphysema (A) - uniform acinar destruction in A1AT deficiency. Centrilobular emphysema (B) - respiratory bronchiole-predominant destruction in smoking (Rosen's Emergency Medicine)

B. Oxidative Stress

Cigarette smoke ROS
       +
Activated macrophage/neutrophil ROS (NOX2, NOX4)
       ↓
Overwhelm antioxidant defenses (glutathione, SOD, catalase, Nrf2-regulated enzymes)
       ↓
   ┌────────────────────────────────────────┐
   ↓                                        ↓
Inactivate A1AT           Activate NF-κB transcription factor
(↑ proteolysis)           (↑ IL-8, TNF-α, IL-1β → more neutrophils/macrophages)
   ↓                                        ↓
Alveolar wall destruction       More ROS generated → self-perpetuating loop

• NF-κB activation: the master switch for proinflammatory gene transcription - drives IL-8, TNF-α, IL-1β, MMP expression
• Nrf2 (transcription factor): the master antioxidant switch - activates superoxide dismutase (SOD), glutathione peroxidase, catalase. Impaired in COPD - its deficiency increases susceptibility to emphysema
• NOX4: a NADPH oxidase isoform highly expressed in airway smooth muscle and fibroblasts in COPD; generates H₂O₂, promoting inflammation and remodeling
• ROS also trigger alveolar epithelial cell apoptosis and mitochondrial dysfunction

C. Alveolar Cell Apoptosis and Impaired Repair

• CD8+ T cells (perforin/granzyme) and ROS (via mitochondrial pathway) drive alveolar type I and type II pneumocyte apoptosis
• Normally, alveolar type II cells regenerate and repair alveolar walls
• In COPD, this repair capacity is exhausted - possibly through cellular senescence (accelerated aging)
• SOD mimetics (which scavenge ROS) prevent alveolar cell apoptosis and emphysema in animal models, confirming this link
• Result: net alveolar destruction exceeds repair → progressive airspace enlargement

Step 5: Structural Remodeling

Large Airway (Chronic Bronchitis) Remodeling

1. Mucous gland hypertrophy - submucosal glands enlarge (Reid Index elevated >0.4)
2. Goblet cell metaplasia - replacement of ciliated epithelium with mucus-secreting goblet cells in bronchi and bronchioles (normally absent in bronchioles)
3. Mucociliary dysfunction - cilia damaged by cigarette smoke; reduced ciliary beat frequency
4. Submucosal inflammation - macrophages, neutrophils, lymphocytes (not eosinophils)

Small Airway (Bronchiolar) Disease - The "Quiet Zone"

• Small airways (<2 mm) contribute little to total airway resistance normally
• Inflammation → goblet cell metaplasia, mucus plugging, mural inflammation
• Fibroblast activation → submucosal fibrosis → luminal narrowing (irreversible)
• Loss of alveolar attachments reduces radial traction holding bronchioles open
• Severe: bronchiolitis obliterans - complete luminal obliteration by fibrous tissue
• This small airway narrowing is the primary fixed component of airflow obstruction in COPD

Pulmonary Vascular Remodeling

• Chronic hypoxia → hypoxic pulmonary vasoconstriction (HPV) - mediated by inhibition of K⁺ channels in smooth muscle, causing depolarization and Ca²⁺ influx
• Hypercapnia potentiates HPV
• Sustained HPV → intimal hyperplasia and smooth muscle hypertrophy of pulmonary arteries
• Progressive loss of pulmonary capillary bed (from parenchymal destruction) reduces the vascular cross-sectional area
• Combined effect: pulmonary hypertension → RV pressure overload → cor pulmonale

Step 6: Systemic Effects of Lung Inflammation

Master Summary Diagram

SMOKING / NOXIOUS PARTICLES  +  GENETIC SUSCEPTIBILITY (A1AT deficiency, etc.)
                    ↓
         Airway epithelial injury
                    ↓
    ┌───────────────────────────────────┐
    ↓                                   ↓
Innate immunity                    Epigenetic changes
(neutrophils, macrophages)         (HDAC inhibition → NF-κB sustained)
    ↓                                   ↓
Adaptive immunity                  Persistent inflammation
(CD8+ T cells, Th17)               even after smoking cessation
    ↓
Three converging pathways:
  1. PROTEASE EXCESS (NE, MMP-9, MMP-12) + A1AT inactivation
       → Alveolar wall & ECM destruction → EMPHYSEMA
  2. OXIDATIVE STRESS (NOX4, ROS) → NF-κB → proinflammatory amplification
       → Apoptosis, impaired repair → ACCELERATED AIRSPACE LOSS
  3. AIRWAY REMODELING (IL-13, NE, IL-17)
       → Goblet cell metaplasia, mucous gland hypertrophy, submucosal fibrosis
       → CHRONIC BRONCHITIS + SMALL AIRWAY OBSTRUCTION
                    ↓
       IRREVERSIBLE AIRFLOW OBSTRUCTION (FEV1/FVC < 0.7)
                    ↓
     V/Q mismatch → Hypoxia → HPV → Pulmonary Hypertension → Cor Pulmonale
     ↑Dead space → ↑WOB → Dynamic hyperinflation → Type II respiratory failure
                    ↓
              SYSTEMIC EFFECTS (muscle, cardiovascular, bone, metabolic)

• Robbins & Kumar Basic Pathology, pp. 447-450
• Fishman's Pulmonary Diseases and Disorders, pp. 395-396
• Rosen's Emergency Medicine, pp. 942-944
• Fuster and Hurst's The Heart, 15th Ed.
• Murray & Nadel's Textbook of Respiratory Medicine